does retatrutide lower libido Side Effects: Muscle Loss, Dosing Risks and Protocol When GLP-1 Medications Affect Libido:
Description
Medicine in Drug Discovery
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, currently in clinical trials for obesity and type 2 diabetes
2021: More than 10,000 semaglutide-related adverse events are reported to the FDA Adverse Reporting System (FAERS)
GLP-3RT is a research-grade triple agonist peptide that activates GLP-1, GIP, and glucagon receptors
Scientific Reports, 15, 16512
